Clinical Trial Update: Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis [Phase 3]

View source ↗

Summary

A Phase 3 trial reports that probiotic supplementation reduces GI symptoms during therapy and improves therapeutic response in immunoglobulin light-chain amyloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Light Chain Amyloidosis

Drugs mentioned

• Probiotic supplementation

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Immunoglobulin Light-chain Amyloidosis | Phase 3 | Status: UNKNOWN